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Abstract
Morin is a flavonol antioxidant. In ethanol – water mixtures (70 wt % of ethanol) it reacts with Al3+ to give Al(Morin)2
in the pH range 3–6. The conditional stability constant of this complex at 298 K was found to be log β2 = 16.96 ± 0.02
at pH 4.40. The complex shows strong fluorescence emission at 500 nm upon excitation at 410 nm. The fluorescence in-
tensity is pH dependent with maximum emission at pH 4.40. Since the complexation reaction enhances the fluorescen-
ce of morin, this property was used for the determination of morin in human serum. A linear dependence of the intensity
of fluorescence of the complex on the concentration of morin was obtained in morin concentration range from 1.5–30.5
ng mL–1, relative standard error of measurements was 1.4 %. The LOD was 0.02 ng mL–1 while LOQ was 1.0 ng mL–1.
Serum concentration of morin was also determined using HPLC as a reference method. A C-18 Hypersil Gold AQ co-
lumn was used with acetonitrile – 0.1% v/v phosphoric acid (30:70% v/v) as the mobile phase at 1.0 mL min–1 flow ra-
te and UV detection at 250 nm. Acceptable relative standard errors (less than 5%) between determinations obtained by
the two methods indicate that the fluorescence method is reliable.
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1. Introduction
Flavonoids are a large class of compounds consisted
of A and C rings of benzo-1-pyran-4-quinone and a B
ring, and further subclassified as flavones (basic structu-
re), flavonols (having a hydroxyl group at the 3-position),
isoflavones (B ring binds to the 3-position), flavanones
(2–3 bond is saturated), and catechins (C-ring is 1-pyran),
chalcones (C-ring is opened), and anthocyanidins (C-ring
is 1-pyran, and 1–2 and 3–4 bonds are unsaturated). They
may have a number of substituents such as hydroxyl
and/or methoxyl groups.
Flavones can prevent many diseases including can-
cers through antioxidative action and/or the modulation of
several enzyme functions. For example, they may reduce
coronary heart disease mortality1 by suppressing the oxi-
dation of low-density lipoprotein.2 Anticarcinogenic acti-
vity of flavones is expressed by their agonism and/or anta-
gonism of carcinogenesis-related receptors such as epi-
dermal growth factor,3 arylhydrocarbon receptor4 and es-
trogen receptor β.5 The secretion of cytokines,6–9 and ex-
pression of protein kinases in tumor cell proliferation10, 11
could be modulated by polyphenols. Morin is typical re-
presentative of flavonoids which bears most of their
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physiological functions. Because of that supplemental
formulations containing morin are under investigations.
Thus, it is of interest to develop simple, accurate and pre-
cise method for the determination of morin in human se-
rum. Up to now, analysis of flavonoids has been accom-
plished by thin-layer chromatography,12, 13 gas chromato-
graphy,14, 15 capillary electrophoresis,16–21 electrochemical
measurements,22–24 high-performance liquid chromato-
graphy (HPLC).12, 25–29 Especially, HPLC was widely used
to separate and analyse flavonoids.
Morin can selectively form highly colored and fluo-
rescent complexes with aluminium, and has long been
used for analysis of aluminium. Morin is weakly fluores-
cent by itself but forms highly fluorescent complex with
aluminium.30–32 Hollman et al.33 applied aluminium nitra-
te as a post-column reagent in RP-HPLC with fluorescen-
ce detection to determine flavonols including quercetin,
morin, and the like, in biological fluids. The comparative
studies showed that the aluminium –morin complex had
the strongest fluorescence intensity. Thus we thought to
utilize the complexation reaction between aluminium and
morin for the determination of morin in human plasma ba-
sed on highly intensive fluorescence of aluminium-morin
complex. As a reference method we used modified RP-
HPLC determination of morin based on extraction of mo-
rin from serum samples with ether – acetone mixture. 34
2. Experimental
2. 1. Reagents and Solutions
Aluminium-nitrate, morin (Fluka AG), ethanol, Na-
OH, CH3COOH (Merck) all p.a. grade, have been used.
All reagents were used without further purification.
The stock solution of aluminium-nitrate was prepared
by dissolving aluminium-nitrate in doubly distilled water.
The content of Al was determined gravimetrically by preci-
pitation with ammonia. The solution of morin was prepared
by dissolving precisely measured mass of morin in 70 wt %
of ethanol. This solution was stored in refrigerator.
Working solutions have been prepared by dilution of
1.0 × 10–4 mol L–1 Al(NO3)3 and 1.0 × 10
–4 mol L–1 morin
respectivelly.
Human pool serum was obtained from Department
of Transfusion of the clinical hospital “Dr Dragisa Miso-
vic”, Belgrade, Serbia.
All measurements were made in acetate buffers (in
70 wt % ethanol) which had been prepared according to
Perrin.35
2. 2. Instruments
Fluorescence spectra were collected using a Fluoro-
log-3 spectrofluorimeter (Jobin Yvon Horiba, Paris, Fran-
ce) equipped with a 450 W xenon lamp and a photomulti-
plier tube. Samples were placed in a 1-cm optical path
length quartz cuvette for spectral recording. The slits on
the excitation and emission beams were fixed at 4 and 3
nm, respectively. The spectra were corrected for the dark
counts. In each measurement, three scans with one- se-
cond-integration time, were averaged. The emission spec-
trum of the solvent (ethanol) was subtracted. All measure-
ments were performed at 24 oC controlled by a Peltier ele-
ment. Measurements of pH were caried out using pH-me-
ter Metler Toledo mp 120 (accuracy of ±0,01 pH unit) and
combined electrode.
The HPLC apparatus (Shimadzu, Japan) included
quaternary pump, LC-20AT, degasser, DGU-20A3, injec-
tor 7125 (20 μL), column thermostat CTO-20A and uv
diode array SPD-M20A. Acquisition and data analysis
were performed with manufacturer software LC Solution.
The RP-18 column was Thermo-Fisher (USA) Hypersil
Gold AQ (150 × 4.6 mm, 5.0 μm). Mobile phase consisted
of acetonitrile/0.1% phosphoric acid at 30:70 v/v % ratio
with a flow rate 1 mL min–1 and injected volume 20 μL.
Wavelength of detection was 250 nm.
3. Results and Discussion
3. 1. Complex Formation Between Morin
and Aluminium(III) -ion
Morin and aluminium(III)-ion upon reaction in etha-
nolic solution form the yellow orange complex in the pH
range 3.0–6.0. The fluorescence spectra were recorded us-
ing ethanol as a blank and excitation and emission wave-
lenghts maxima were λex = 410 nm and λem = 500 nm, res-
pectively.
The fluorescence of the morin solution (c = 2.0 ×
10–7 mol L–1) incereases upon addition of Al3+ ion. This
is expected since Al3+ forms a fluorescent complex (es)
Fig. 1: Method of molar ratios. Dependence of intensity of fluores-
cence on molar ratio cmor/cAl3+
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with morin of general formula Al(morin)n. The response
is linear from 1.0 × 10–8 to 2.0 × 10–6 mol L–1 Al3+. Abo-
ve the ∼s 5.0 × 10–6 mol L–1 Al3+ the response levels off
due to saturation of all binding sites in morin. The same
type of response is obtained for Al3+ solution with the
addition of varying concentrations of morin. The stoic-
hiometry of the complexation was investigated by using
Job36 and molar ratio37 methods. At pH 4.40 the most
probable stoichiometry is n = 2. The composition of alu-
minium –morin complex was also estimated by the mole
ratio method. The result is shown in Fig. 1 which con-
firms the aluminium to morin ratio 1:2 for the complex
formed at pH 4.40. This indicates that complexation
equilibria are not stepwise and the complex is formed in
a single step.
The stability constant of the complex at pH 4.40 was
estimated from Jobb’s plot and (conditional) stability con-
stant was found to be log K = 16.96 ± 0.02. To examine
the dependence of fluorescence intensity on pH the mea-
surements were made in acetate buffers (in 70 wt % etha-
nol) of different pH values, prepared according to Per-
rin.35 By subtracting relevant intensity of fluorescence of
the Al (NO3)3 and morin solutions from their mixture, the
curve I = f (pH) was obtained (Fig. 2).
The pH dependence of fluorescence intensity exhi-
bits a complex shape. At low pH intensity decreases be-
cause protons tend to displace Al3+. At pH higher ∼s 5.0
intensity again falls off because more of the Al3+ is in the
form of hydroxide complexes.
3. 2. The Quantitative Determination 
of Morin
The formation of a stable aluminium-morin com-
plex in ethanolic solution with enhanced fluorescence can
be utilized for quantitative determination of morin in vari-
ous matrices in trace amounts. We chosed to develop and
validate a method for the determination of morin in hu-
man serum.
3. 2. 1. Calibration Graph in Aqueous – 
Ethanolic Phase
Linearity
The high value of the stability constant of the alu-
minium – morin complex ensures the quantitative deter-
mination of morin using the complex. The calibration
curve method was used, requiring solutions containing
constant concentration of Al(NO3)3 and different concen-
trations of morin in acetate buffer (using 70 wt % ethanol
as solvent) with pH 4.40. Blank was acetate buffer at pH
4.40. Linear dependence of the intensity of fluorescence
of the complex on the concentration of morin was obtai-
ned in the interval 1.5–30.5 ng mL–1. The regression
equation:
I = (3.19 ± 0.07) c + (0.81 ± 0.04) (1)
was calculated, where I is fluorescence intensity in % (λem
= 500 nm) and c is concentration in ng mL–1. The good li-
nearity of calibration curve and negligible scatter of expe-
rimental points are representing by the high correlation
coefficient, r = 0.99874.
LOD (Limit of Detection) and LOQ (Limit of 
Quantification)
The limit of detection (LOD) 38, 39 was calculated by
establishing the minimum level at which morin can be de-
tected, according to formula
LOD = 3.3 sa/a (2)
where sa is standard deviation in intercept and a is a
slope of calibration line. It was found that LOD in aque-
ous-ethanolic solution is 0.015 ng mL–1.
The limit of quantification (LOQ)38, 39 was determi-
ned by using the formula:
LOQ = 10 sa/a (3)
Morin can be quantified at a concentration of 0.045
ng mL–1 in aqueous – ethanolic solutions.
Precision
The accuracy of the method was determined for
three different morin concentrations (Table 1). The repea-
tability of the method is fairly high as indicated by low
values of SD. The results obtained by proposed procedu-
re indicate that the method is precise for the determina-
tion of morin in ethanolic media. The results are shown in
Table 1.
Fig. 2: Dependence of intensity of fluorescence on the pH
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3. 2. 2. Determination of Morin in Human Serum
Calibration graph and procedure for human serum
A 0.2 mL human pool serum and 8.8 mL acetate
buffer (in 70 wt % ethanol) pH 4.40, were mixed with
standard solution of morin to give concentrations
1.5–30.5 ng mL–1 of morin (total volume 10 mL). After in-
cubation, a 0.5 mL of 1 × 10–6 mol L–1 Al(NO3)3 was ad-
ded. Fluorescence spectra of prepared solutions were ta-
ken at λex= 410 nm and λem = 500 nm, against the serum in
acetate buffer (pH 4.40). Linear dependence of the inten-
sity of fluorescence of the complex on the concentration
of morin in diluted serum samples was obtained in the in-
terval 1.5–30.5 ng mL–1. The regression equation:
I = (3.30 ± 0.05) c + (0.76 ± 0.03) r = 0.99944 (4)
was calculated, where I is fluorescence intensity in %, and
c is concentration of morin in ng mL–1. The limit of detec-
tion (LOD) of morin in serum was calculated and it was
0.02 ng mL–1. The limit of quantification (LOQ) of morin
in serum was found to be 0.06 ng mL–1.
To assay the accuracy of the method tree different
concentrations of morin were added to a human serum in
order to get its concentrations of morin in the interval
0.152–0.455 μg mL–1. These serum samples were treated
in the same way as for the calibration graph. After addi-
tion of Al(NO3)3 and buffer solutions, and appropriate di-
lution, concentrations of morin in solutions were
3.03–9.09 ng mL–1. Analytical recovery was 100–
100.15%. Low values of relative error and relative stan-
dard deviation of determination (R.S.D.) indicate very
good reproducibility of measurement. The results of the
assay are shown in Table 2.
3. 2. 3. HPLC Determination
To check the reliability of fluorescence method the
direct HPLC determination of morin in serum samples
was developed as a modification of reported method.34
Two calibration curves were established for the determi-
nation of morin. One curve was constructed in aqueous
phase while the other was obtained from serum. The sam-
ples were spiked with various concentrations of morin
stock solution (in methanol) to afford of a series of aque-
ous phase consisting of 1.6, 6.4, 25.0, 50.0, 100.0 and
200.0 μg mL–1 of morin.
The calibration curve was obtained by direct injec-
tion of working solution into a column. The serum cali-
bration curve was obtained by spiking 200 μL of blank se-
rum containing 100 μL acetate buffer (pH 4.50) by diffe-
rent concentration levels of the standard solution of morin
in methanol. The range of morin concentrations thus co-
vered was 1.0 to 200 μg mL–1 (6 solutions). The solutions
were incubated at 37 °C for 30 min, thoroughly shaken
and then 300 μL of the mixture of ether and acetone
(90:10 v/v %) was added and the mixture was again sha-
ken on a shaker. The ether layer was evaporated under ni-
trogen atmosphere and reconstituted with mobile phase
and then subjected to HPLC analysis. Validation parame-
ters are given in Table 3.
Recovery was calculated as the ratio between slopes
of calibration curves in aqueous phase and in serum. The
obtained value of 86% is in acceptable range.
The HPLC method was already applied to determi-
nation of morin in mixture of morin and quercetin toget-
her with their conjugated metabolites in serum.34 Spec-
trofluorimetry enables direct and simple determination of
morin without the extraction required for HPLC method.
Spectrofluorimetry also provides much lower LOD values
than HPLC what undoubtedly is an advantage since nons-
pecific emission from serum is eliminated by high dilu-
tion. HPLC method on the other hand separates morin
from protein and other interfering components of serum
thus enabling, accurate and precise results. In HPLC met-
hod longer incubation time was used leading to metaboli-
Table 1: The spectrofluorimetric determination of morin in aque-
ous – ethanolic solutions
Taken  Found Recovery(%) SD CV(%)
(ng mL–1) (mg mL–1)
3.03     2.95 97.4 2.5 × 10–2 0.84
6.06     6.08 100.4 2.9 × 10–2 0.47
9.09 9.14 100.6 2.8 × 10–2 0.31
n = 3
Table 2: Accuracy and precision of the spectrofluorimetric deter-
mination of morin in serum samples
Taken  Found Recovery(%) SD CV(%)
(μg mL–1) (μg mL–1)
0.1515 0.1515 100.00 2.1 × 10–3 1. 40
0.3030 0.3036 100.15 3.5 × 10–3 1.15
0.4545 0.4551 100.11 3.5 × 10–3 0.77
n = 3
Table 3: Validation parameters of HPLC determination of morin in human pool serum 
Serum Aqueous phase
Linearity (n = 6) Y = (4.29 ± 0.08)×103 X + Y = (5.0 ± 0.1)103 X +Y 
(5.56 ± 0.08)103 (10.9 ± 0.1)103
Y (peak area), X (conc. of morin in μg mL–1)
Coefficient of correlation (r) 0.9987 0.9988
LOD (μg mL–1) 0.056 0.055
LOQ  (μg mL–1) 0.169 0.166
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te transformations of morin. This provides lower recovery
in comparison with the recovery obtain by spectrofluo-
rimetric method.
In comparison with other methods reported,34,40,41
this method is quick and simple, and has high sensitivity,
wide linear range and good stability.
4. Conclusions
We obtained that the fluorescence intensity of the
aluminium – morin complex, at maximum λem= 500 nm,
is linear function of morin concentration, in the presence
of excess of Al3+ ions. On the basis of these results we can
propose that the spectrofluorimetric method can be used
for quantitative determination of morin in human serum.
Reference HPLC method confirmed the results obtained
spectrofluorimetrically.
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Povzetek
Morin je flavonoidni antioksidant. V me{anici etanol – voda (70 ut. % etanola) reagira z Al3+, pri ~emer nastane v pH
obmo~ju med 3 in 6 kompleks Al(Morin)2. Logaritem pogojne konstante stabilnosti (β2) tega kompleksa je pri 298 K in
pH 16.96 ± 0.02. Kompleks ka`e pri vzbujevalni valovni dol`ini 410 nm fluorescen~ni emisijski maksimum pri 500 nm.
Intenziteta je odvisna od pH in je najve~ja pri pH 4.40. Ker nastanek kompleksa pove~a fluorescenco morina, je bila ta
lastnost uporabljena za dolo~anje morina v ~love{kem serumu. Ugotovljena je bila linearna odvisnost intenzitete emiti-
rane svetlobe od koncentracije morina v obmo~ju med 1.5 ter 30.5 ng mL–1. Relativna standardna napaka meritev je pri
bila 1.4 %, meja zaznave 0.02 ng mL–1 ter meja kvantifikacije 1.0 ng mL–1. Koncentracije morina v seruma so bile dolo-
~ene tudi z referen~no HPLC metodo z uporabo C-18 Hypersil Gold AQ kolone in mobilno fazo acetonitril –0.1 % fos-
forna kislina (30:70 % v/v) pri pretoku 1.0 mL min–1 in UV detekcijo pri 250 nm. Sprejemljive relativne standardne na-
pake (manj kot 5 %) dobljene na osnovi primerjave rezultatov z referen~no HPLC metodo potrjujejo zanesljivost fluo-
rescen~ne metode.
